BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7786787)

  • 1. Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome.
    Russell SJ; Nisen PD
    Br J Haematol; 1995 May; 90(1):210-2. PubMed ID: 7786787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation.
    Andreu N; Pujol-Moix N; Martinez-Lostao L; Oset M; Muñiz-Diaz E; Estivill X; Volpini V; Fillat C
    Blood Cells Mol Dis; 2003; 31(3):332-7. PubMed ID: 14636648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
    Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
    Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.
    Notarangelo LD; Parolini O; Porta F; Locatelli F; Lanfranchi A; Marconi M; Nespoli L; Albertini A; Craig IW; Ugazio AG
    Hum Genet; 1991 Dec; 88(2):237-41. PubMed ID: 1684569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical Wiskott-Aldrich syndrome in a girl.
    Conley ME; Wang WC; Parolini O; Shapiro DN; Campana D; Siminovitch KA
    Blood; 1992 Sep; 80(5):1264-9. PubMed ID: 1515642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.
    De Saint-Basile G; Schlegel N; Caniglia M; Le Deist F; Kaplan C; Lecompte T; Piller F; Fischer A; Griscelli C
    Ann Hematol; 1991 Aug; 63(2):107-10. PubMed ID: 1912030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia.
    Boonyawat B; Dhanraj S; Al Abbas F; Zlateska B; Grunenbaum E; Roifman CM; Steele L; Meyn S; Blanchette V; Scherer SW; Swierczek S; Prchal J; Zhu Q; Torgerson TR; Ochs HD; Dror Y
    J Clin Immunol; 2013 Oct; 33(7):1150-5. PubMed ID: 23943155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome.
    Wengler G; Gorlin JB; Williamson JM; Rosen FS; Bing DH
    Blood; 1995 May; 85(9):2471-7. PubMed ID: 7537115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation.
    Puck JM; Siminovitch KA; Poncz M; Greenberg CR; Rottem M; Conley ME
    Blood; 1990 Jun; 75(12):2369-74. PubMed ID: 1972030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro response of peripheral blood lymphocytes from patients with Wiskott-Aldrich syndrome.
    Marinkovich VA
    Clin Allergy; 1972 Mar; 2(1):69-78. PubMed ID: 4275189
    [No Abstract]   [Full Text] [Related]  

  • 11. Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.
    Lau YL; Jones BM; Low LC; Wong SN; Leung NK
    Eur J Pediatr; 1992 Sep; 151(9):680-3. PubMed ID: 1396930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytes.
    Dragone L; Pallant A; Insel R; Frelinger JG
    Exp Clin Immunogenet; 1992; 9(3):130-40. PubMed ID: 1338889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X chromosome inactivation patterns in leucocyte populations of female carriers of Wiskott-Aldrich syndrome with an atypical presentation.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Immunodeficiency; 1993; 4(1-4):267-9. PubMed ID: 8167716
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier detection in the Wiskott Aldrich syndrome.
    Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
    Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
    Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmed diagnosis of classic Wiskott-Aldrich syndrome in East Africa: a case report.
    Kiputa M; Urio O; Maghembe A; Kombo D; Dhalla S; Ndembo V; Muze K; Kahwa M; Fakih Z; Kija E
    J Med Case Rep; 2022 Jul; 16(1):301. PubMed ID: 35897083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of X-chromosome inactivation in bone marrow precursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming-unit.
    Mantuano E; Candotti F; Giliani S; Parolini O; Lusardi M; Zucchi M; Lanfranchi A; Porta F; Airò P; Albertini A
    Immunodeficiency; 1993; 4(1-4):271-6. PubMed ID: 8167717
    [No Abstract]   [Full Text] [Related]  

  • 19. X-linked Wiskott-Aldrich syndrome in a girl.
    Parolini O; Ressmann G; Haas OA; Pawlowsky J; Gadner H; Knapp W; Holter W
    N Engl J Med; 1998 Jan; 338(5):291-5. PubMed ID: 9445409
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of molecular analysis to genetic counseling in the Wiskott-Aldrich syndrome (WAS).
    Notarangelo LD; Candotti F; Parolini O; Mantuano E; Giliani S; Lanfranchi A; Albertini A
    DNA Cell Biol; 1993 Sep; 12(7):645-9. PubMed ID: 8397823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.